Almon Einat Brill (CIK 0001385116)

Latest company ownership

PLX - Protalix BioTherapeutics, Inc.
Role: SVP, Product Development
Shares held
196,995
Last filed at
Jun 8, 2020
Confidence Score
50.0
2025Q4
Confidence Score History
2008Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
May 2, 2012 May 4, 2012 Protalix BioTherapeutics, Inc. SVP, Product Development Sell 5.0 -166,848 -100.00% ✓ $1.2M
Oct 4, 2010 Oct 6, 2010 Protalix BioTherapeutics, Inc. VP, Product Development Sell 7.5 -70,000 -100.00% ✓ $636.7K
Sep 3, 2010 Sep 8, 2010 Protalix BioTherapeutics, Inc. VP, Product Development Sell 7.5 -50,000 -100.00% ✓ $403.6K
Oct 15, 2009 Oct 19, 2009 Protalix BioTherapeutics, Inc. VP, Product Development Sell 7.5 -93,954 -100.00% ✓ $884.1K
Jul 6, 2009 Jul 8, 2009 Protalix BioTherapeutics, Inc. VP, Product Development Sell 7.5 -59,822 -100.00% ✓ $304K
May 18, 2009 May 19, 2009 Protalix BioTherapeutics, Inc. VP, Product Development Sell 22.5 -44,707 -100.00% ✗ $177.8K
May 11, 2008 May 14, 2008 Protalix BioTherapeutics, Inc. VP, Product Development Buy 22.5 -6,943 -14.35% ✗ $94.6K